Centex Studies Inc. - Dr. Garcia — Pharr, Texas

Centex Studies Inc. - Dr. Garcia is a clinical research site located in Pharr, Texas, United States 78577.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Centex Studies Inc. - Dr. Garcia has participated in 1 clinical trials.

Therapeutic areas: Influenza.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pharr

Browse all research sites in Texas · View every site in Pharr

• GSK Investigational Site
• Research Site
• Centex Studies
• GLRI McAllen Research
• Influence Study Site
• Rio Grande Valley Clinical Research Institute
• Exygon Clinical Research
• Local Institution - 0303
• McAllen Research
• Great Lakes Research Institute
• Synergy Research Site
• Akero Clinical Study Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Centex Studies Inc. - Dr. Garcia?

Centex Studies Inc. - Dr. Garcia has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Centex Studies Inc. - Dr. Garcia conducted?

Centex Studies Inc. - Dr. Garcia has 1 clinical trials on record. Their work covers Influenza.

Is Centex Studies Inc. - Dr. Garcia accredited by Crixeo Clinical Trials?

Centex Studies Inc. - Dr. Garcia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Centex Studies Inc. - Dr. Garcia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.